Dayvigo OverviewLemborexant (INN) (code name E-2006, brand name Dayvigo) is a medication for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults. Lemborexant was approved in the United States for use by adults with insomnia in December 2019. Lemborexant is a dual antagonist of the orexin OX1 and OX2 receptors. In June 2016...
Read more Dayvigo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lemborexant
Recent Dayvigo Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 10mg, 5mg